You can purchase shares of PROSTATYPE GENOMICS AB by Prostatype Genomics AB (OTCQB:PGABF) through any online brokerage.
There are no as such competitors for PROSTATYPE GENOMICS AB by Prostatype Genomics AB.
There is no analysis for PROSTATYPE GENOMICS AB by Prostatype Genomics AB to provide a consensus price target.
The stock price for PROSTATYPE GENOMICS AB by Prostatype Genomics AB (OTCQB: PGABF) is $0.0088 last updated October 7, 2026 at 9:30 AM EDT.
There are no upcoming dividends for PROSTATYPE GENOMICS AB by Prostatype Genomics AB.
PROSTATYPE GENOMICS AB by Prostatype Genomics AB does not have any upcoming earnings scheduled.
There is no upcoming split for PROSTATYPE GENOMICS AB by Prostatype Genomics AB.
PROSTATYPE GENOMICS AB by Prostatype Genomics AB is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. By assessing the aggressiveness of prostate cancer, Prostatype helps clinicians and patients to make correct treatment decisions. Over and under treatment of...